Skip to main content
Let's spread the word about Immunotherapy! Click to share this page with your community.

Video: Watch These Facebook Live Updates on Cancer Immunotherapy with CRI Experts

October 07, 2016

 Recently, Cancer Research Institute CEO and Director of Scientific Affairs Jill O’Donnell-Tormey, Ph.D., appeared in two informative Facebook Live broadcasts to discuss current developments and challenges in cancer immunotherapy.

Last week, during the Second International Cancer Immunotherapy Conference (CICON16), O’Donnell-Tormey moderated a Q&A panel with renowned cancer immunology experts Elizabeth Jaffee, M.D., of Johns Hopkins Medicine and Philip Greenberg, M.D., of Fred Hutchinson Cancer Research Center.

Earlier this week, O’Donnell-Tormey sat down with Business Insider’s pharmaceutical and biotech reporter Lydia Ramsey to share the latest advancements in cancer immunotherapy, and highlight CRI’s role in pioneering and leading this vital new field of cancer treatment.

We are grateful for the continued opportunities to provide updates on cancer immunotherapy’s progress and promising future.

Be in the know with the latest immunotherapy news

*Immunotherapy results may vary from patient to patient.

Top